NO800744L - Diagnosefremgangsmaate og utrustning til gjennomfoering av denne. - Google Patents
Diagnosefremgangsmaate og utrustning til gjennomfoering av denne.Info
- Publication number
- NO800744L NO800744L NO800744A NO800744A NO800744L NO 800744 L NO800744 L NO 800744L NO 800744 A NO800744 A NO 800744A NO 800744 A NO800744 A NO 800744A NO 800744 L NO800744 L NO 800744L
- Authority
- NO
- Norway
- Prior art keywords
- cells
- migration
- serum
- medium
- cell
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 23
- 238000003745 diagnosis Methods 0.000 title claims description 4
- 230000005012 migration Effects 0.000 claims description 57
- 238000013508 migration Methods 0.000 claims description 57
- 210000004027 cell Anatomy 0.000 claims description 48
- 210000002966 serum Anatomy 0.000 claims description 33
- 241000282887 Suidae Species 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 18
- 210000002889 endothelial cell Anatomy 0.000 claims description 15
- 238000004264 monolayer culture Methods 0.000 claims description 14
- 206010052428 Wound Diseases 0.000 claims description 13
- 208000027418 Wounds and injury Diseases 0.000 claims description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 201000001320 Atherosclerosis Diseases 0.000 claims description 10
- 210000000709 aorta Anatomy 0.000 claims description 9
- 230000012292 cell migration Effects 0.000 claims description 6
- 238000002405 diagnostic procedure Methods 0.000 claims description 6
- 241001465754 Metazoa Species 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000010410 layer Substances 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- 210000003855 cell nucleus Anatomy 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims 3
- 210000001367 artery Anatomy 0.000 claims 1
- 239000002609 medium Substances 0.000 description 13
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 230000000923 atherogenic effect Effects 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 7
- 230000003143 atherosclerotic effect Effects 0.000 description 6
- 238000004113 cell culture Methods 0.000 description 6
- 230000037213 diet Effects 0.000 description 6
- 210000003038 endothelium Anatomy 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- 239000012894 fetal calf serum Substances 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000003511 endothelial effect Effects 0.000 description 2
- 239000012737 fresh medium Substances 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 229940104230 thymidine Drugs 0.000 description 2
- 210000003606 umbilical vein Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010072810 Vascular wall hypertrophy Diseases 0.000 description 1
- 210000002403 aortic endothelial cell Anatomy 0.000 description 1
- 210000004618 arterial endothelial cell Anatomy 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000012332 laboratory investigation Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000004940 nucleus Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000035752 proliferative phase Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 231100000588 tumorigenic Toxicity 0.000 description 1
- 230000000381 tumorigenic effect Effects 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Strength Of Materials By Application Of Mechanical Stress (AREA)
- Communication Control (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Investigating Materials By The Use Of Optical Means Adapted For Particular Applications (AREA)
- Furnace Housings, Linings, Walls, And Ceilings (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Coating With Molten Metal (AREA)
- Application Of Or Painting With Fluid Materials (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Molding Of Porous Articles (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH245479 | 1979-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO800744L true NO800744L (no) | 1980-09-16 |
Family
ID=4234190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO800744A NO800744L (no) | 1979-03-15 | 1980-03-14 | Diagnosefremgangsmaate og utrustning til gjennomfoering av denne. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4403041A (fr) |
| EP (1) | EP0016425B1 (fr) |
| JP (1) | JPS5681449A (fr) |
| AT (1) | ATE15944T1 (fr) |
| AU (1) | AU538833B2 (fr) |
| CA (1) | CA1170555A (fr) |
| DE (1) | DE3071132D1 (fr) |
| DK (1) | DK112980A (fr) |
| ES (1) | ES8102802A1 (fr) |
| FI (1) | FI800724A (fr) |
| GR (1) | GR67652B (fr) |
| IL (1) | IL59624A (fr) |
| NO (1) | NO800744L (fr) |
| NZ (1) | NZ193126A (fr) |
| PT (1) | PT70950A (fr) |
| ZA (1) | ZA801519B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3531966A1 (de) * | 1985-09-07 | 1987-03-12 | Arnim Ulrich Christoph Von | Verfahren zur langzeit-zuechtung beliebiger endothelzellen, methode zu ihrer identifizierung und charakterisierung und ihre verwendung fuer diagnose und klaerung der aetiopatogenese von krankheitszustaenden |
| US7708977B2 (en) * | 2002-11-15 | 2010-05-04 | The United States Of America As Represented By The Department Of Health And Human Services | Method for diagnosis and treatment of vascular disease |
| US20070282316A1 (en) * | 2006-06-05 | 2007-12-06 | Cryocath Technologies Inc. | Method of prophylactically treating an artery to make it resistant to the subsequent development of atherosclerosis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1055851B (it) * | 1974-08-30 | 1982-01-11 | Behringwerke Ag | Particelle indicatirci per diagnosi in vitro |
| US4059486A (en) | 1976-11-03 | 1977-11-22 | Monsanto Company | Cell culture process |
| US4299814A (en) * | 1979-05-25 | 1981-11-10 | Monsanto Company | Radioimmunoassay of MIF |
-
1980
- 1980-03-10 FI FI800724A patent/FI800724A/fi not_active Application Discontinuation
- 1980-03-10 US US06/128,744 patent/US4403041A/en not_active Expired - Lifetime
- 1980-03-13 ES ES489502A patent/ES8102802A1/es not_active Expired
- 1980-03-13 GR GR61433A patent/GR67652B/el unknown
- 1980-03-13 CA CA000347587A patent/CA1170555A/fr not_active Expired
- 1980-03-13 EP EP80101311A patent/EP0016425B1/fr not_active Expired
- 1980-03-13 DE DE8080101311T patent/DE3071132D1/de not_active Expired
- 1980-03-13 AT AT80101311T patent/ATE15944T1/de not_active IP Right Cessation
- 1980-03-14 JP JP3170880A patent/JPS5681449A/ja active Pending
- 1980-03-14 IL IL59624A patent/IL59624A/xx unknown
- 1980-03-14 DK DK112980A patent/DK112980A/da not_active Application Discontinuation
- 1980-03-14 NO NO800744A patent/NO800744L/no unknown
- 1980-03-14 ZA ZA00801519A patent/ZA801519B/xx unknown
- 1980-03-14 PT PT70950A patent/PT70950A/pt unknown
- 1980-03-14 AU AU56469/80A patent/AU538833B2/en not_active Ceased
- 1980-03-14 NZ NZ193126A patent/NZ193126A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT70950A (de) | 1980-04-01 |
| DE3071132D1 (en) | 1985-11-07 |
| ATE15944T1 (de) | 1985-10-15 |
| AU538833B2 (en) | 1984-08-30 |
| IL59624A0 (en) | 1980-06-30 |
| IL59624A (en) | 1982-11-30 |
| NZ193126A (en) | 1983-02-15 |
| FI800724A (fi) | 1980-09-16 |
| ES489502A0 (es) | 1981-02-16 |
| GR67652B (fr) | 1981-09-02 |
| EP0016425B1 (fr) | 1985-10-02 |
| US4403041A (en) | 1983-09-06 |
| CA1170555A (fr) | 1984-07-10 |
| ES8102802A1 (es) | 1981-02-16 |
| JPS5681449A (en) | 1981-07-03 |
| ZA801519B (en) | 1981-03-25 |
| DK112980A (da) | 1980-09-16 |
| EP0016425A1 (fr) | 1980-10-01 |
| AU5646980A (en) | 1980-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chen et al. | Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases | |
| Clowes et al. | Mechanisms of arterial graft failure. II. Chronic endothelial and smooth muscle cell proliferation in healing polytetrafluoroethylene prostheses | |
| Colin et al. | The effect of uraemia upon wound healing: an experimental study | |
| Trowell | The culture of lymph nodes in vitro | |
| Yashiro et al. | Expression of insulin-like growth factor receptors in primary human thyroid neoplasms | |
| Balinsky | I.—On the developmental processes in mammary glands and other epidermal structures | |
| Zanelli et al. | A bioassay method in vitro for parathyroid hormone | |
| Sömjen et al. | Tissue selective action of tamoxifen methiodide, raloxifene and tamoxifen on creatine kinase B activity in vitro and in vivo | |
| Kaneko et al. | Pituitary of" cobalt" variant of the rainbow trout separated from the hypothalamus lacks most pars intermedial and neurohypophysial tissue | |
| Yoneda et al. | Control of VX2 carcinoma cell growth in culture by calcium, calmodulin, and prostaglandins | |
| Hubbard et al. | Effect of dietary linoleic acid level on lodgement, proliferation and survival of mammary tumor metastases | |
| Sauer et al. | Stimulation of tumor growth in adult rats in vivo during acute streptozotocin-induced diabetes | |
| Van Luyn et al. | Methylcellulose cell culture as a new cytotoxicity test system for biomaterials | |
| NO800744L (no) | Diagnosefremgangsmaate og utrustning til gjennomfoering av denne. | |
| Yuhas et al. | Dormancy and spontaneous recurrence of human breast cancer in vitro | |
| Sheffield et al. | Transplantation of bovine mammary tissue to athymic nude mice: growth subcutaneously and in mammary gland-free fat pads | |
| HINO et al. | Effect of gizzerosine on acid secretion by isolated mucosal cells of chicken proventriculus | |
| Scheinberg et al. | Somatic variation of red cell agglutinogens due to hormonal influence | |
| Masiello et al. | Stimulation of insulin release by glucose in a transplantable rat islet cell tumor | |
| Singer et al. | Expression of antigens by cultured epithelial cells: comparison of epidermis and thymic epithelium | |
| Peralta et al. | Effects of testosterone on skeletal growth in lambs as assessed by labeling index of chondrocytes in the metacarpal bone growth plate | |
| Behera et al. | In vivo and in vitro effects of alloxan on collagen characteristics of bone, skin and tendon of Swiss mice | |
| Csaky et al. | Localization of the ‘sugar pump’in the intestinal epithelium | |
| Bagdade et al. | Atherosclerosis and oral contraceptive use. Serum from oral contraceptive users stimulates growth of arterial smooth muscle cells. | |
| Houlihan et al. | Nerve growth-promoting properties of 1, 1, 3-tricyano-2-amino-1-propene |